4-(2-Chloroethyl)morpholine hydrochloride

We are 4-(2-Chloroethyl)morpholine hydrochloride CAS:3647-69-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-(2-Chloroethyl)morpholine hydrochloride
CAS.NO:3647-69-6
Synonyms:4-(2-Chloroethyl)morpholine hydrochloride
Morpholine, 4-(2-chloroethyl)-, hydrochloride
N-(2-Chloroethyl)morpholine hydrochloride
2-Morpholinoethyl Chloride Hydrochloride
Molecular Formula:C6H13Cl2NO
Molecular Weight:186.08000
 
Physical and Chemical Properties:
Density:1.088
Melting point:180-185ºC
Boiling point:202.8ºC
Flash point:76.4ºC
 
Specification:
Appearance:White to off-white crystalline solid Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Pharmaceutical intermediate

4-(2-Chloroethyl)morpholine hydrochloride


Related News: Once they have decided how to make the compound, our staff in the production department manufacture a high quantity of APIs using the large reactors in our plant.N-[[[2-(Aminooxy)ethyl]amino]sulfonyl]carbamic acid 1,1-dimethylethyl ester Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.4'-metoxiacetoacetanilida CAS:5437-98-9 After this long manufacturing process, it is purified until it reaches a very high degree of purity and finally becomes an API.1-amino-2- (isopropilsulfonil) benceno CAS:76697-50-2 CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.

Related Products
Product Name
5-(4-Chlorobutyl)-1-cyclohexanyl Tetrazole Cas:73963-42-5 View Details
Creatine monohydrate View Details
2,4,6-trichloroaniline Cas:634-93-5 View Details
9-bromo-10-(10-bromoanthracen-9-yl)anthracene manufacturer 5-methyl-2′-deoxycytidine manufacturer SUGAMMADEX Cas:343306-71-8 manufacturer Lutetium Oxide Cas:12032-20-1 manufacturer (3,3,3-TRIFLUOROPROPYL)TRIMETHOXYSILANE Cas:429-60-7 manufacturer